ClinicalTrials.Veeva

Menu

Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye

A

Al-Azhar University

Status

Completed

Conditions

Dry Eye Disease (DED)

Treatments

Drug: Pilocarpine
Drug: artificial tears

Study type

Interventional

Funder types

Other

Identifiers

NCT06752278
Pilocarpine and Dry Eye

Details and patient eligibility

About

Management approaches for dry eye disease (DED) typically start with low-risk, easily accessible, patient-applied therapies like artificial tears for early-stage disease. As the condition worsens, treatment progresses to more advanced therapies for severe forms of DED. This study aims to compare the effectiveness and safety of pilocarpine as a secretagogue versus artificial tears in the treatment of dry eye disease. Our goal is to provide reliable, high-quality evidence regarding the efficacy of secretagogues, thereby contributing to the development of recommendations that aid clinicians in their decision-making process

Enrollment

40 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with DED

Exclusion criteria

  • Previous Occular surgery.
  • Refuse to particupate.
  • Patients with sjogren syndrome

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

pilocarpine group
Active Comparator group
Treatment:
Drug: Pilocarpine
artificial tears group
Active Comparator group
Treatment:
Drug: artificial tears

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems